Advanced search
Publication Cover
Postgraduate Medicine Volume 103, 1998 - Issue 3
Submit an article Journal homepage
25
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Monitoring blood levels of selected drugs

Remember to factor in the many confounding variables

Daniel E. Keyler Dr Keyler is codirector, toxicology research, Minneapolis Medical Research Foundation and department of medicine, division of clinical pharmacology and toxicology, Hennepin County Medical Center, and clinical associate professor, College of Pharmacy, University of Minnesota Medical School, Minneapolis.Correspondence[email protected]
, PharmD,
John T. VanDeVoort Dr VanDeVoort is a postdoctoral fellow, College of Pharmacy, University of Minnesota Medical School. Ms Howard and Dr Jancik are clinical pharmacists, department of pharmacy, and Dr Garrett is division chief, department of medicine, Hennepin County Medical Center.
, PharmD,
Jan E. Howard Dr VanDeVoort is a postdoctoral fellow, College of Pharmacy, University of Minnesota Medical School. Ms Howard and Dr Jancik are clinical pharmacists, department of pharmacy, and Dr Garrett is division chief, department of medicine, Hennepin County Medical Center.
, BSPharm, BCPS,
Jon T. Jancik Dr VanDeVoort is a postdoctoral fellow, College of Pharmacy, University of Minnesota Medical School. Ms Howard and Dr Jancik are clinical pharmacists, department of pharmacy, and Dr Garrett is division chief, department of medicine, Hennepin County Medical Center.
, PharmD, BCPS &
Craig R. Garrett Dr VanDeVoort is a postdoctoral fellow, College of Pharmacy, University of Minnesota Medical School. Ms Howard and Dr Jancik are clinical pharmacists, department of pharmacy, and Dr Garrett is division chief, department of medicine, Hennepin County Medical Center.
, MD
Pages 209-224 | Published online: 30 Jun 2015

References

  • Commission on Antiepileptic Drugs, International League Against Epilepsy. Guidelines for therapeutic monitoring on antiepileptic drugs. Epilepsia 1993; 34(4): 585–7
  • Eadie MJ. The role of therapeutic drug monitoring in improving the cost effectiveness of anticonvulsant therapy. Clin Phar-macokinet 1995; 29(l):9–35
  • Mattson RH. Antiepileptic drug monitoring: a reappraisal. Epilepsia 1995; 36(Suppl 5):22–9S
  • Pellock JM, Willmore LJ. A rational guide to routine blood monitoring in patients receiving antiepileptic drugs. (Editorial) Neurology 1991; 41(7):961–4
  • Troupin AS. Dose-related adverse effects of anticonvulsants. Drug Saf 1996; 14(5):299–328
  • Willmore LJ. Management of epilepsy in the elderly. Epilepsia 1996; 37(Suppl 6): 23–33S
  • Riva R, Albani F, Contin M, et al. Pharmacokinetic interactions between antiepileptic drugs: clinical considerations. Clin Pharmacokinet 1996; 31(6):470–93
  • Lewis RP. Clinical use of serum digoxin concentrations. Am J Cardiol 1992; 69(18): 97–106G
  • Wieland H. Practical aspects of monitoring cardiac drugs in the blood. Med J Aust 1995; 162(10):543–7
  • Gill J, Heel RC, Fitton A. Amiodarone: an overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias. Drugs 1992; 43(1): 69–110
  • Podrid PJ. Amiodarone: reevaluation of an old drug. Ann Intern Med 1995; 122(9):689–700
  • Ellenbogen KA, Wood MA, Stambler BS. Procainamide: a perspective on its value and danger. Heart Dis Stroke 1993; 2(6):473–6
  • Atkinson AJ Jr, Ruo TI, Piergies AA. Comparison of the pharmacokinetic and pharmacodynamic properties of procainamide and N-acetylprocainamide. Angiology 1988; 39(7 Pt 2):655–67
  • Toft AD. Thyroxine therapy. N Engl J Med 1994; 331 (3): 174–80 [Erratum, N Engl J Med 1994;331(15):1035]
  • Roti E, Minelli R, Gardini E, et al. The use and misuse of thyroid hormone. Endoer Rev 1993; 14(4):401–23
  • Surks MI, Chopra IJ, Mariash CN, et al. American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA 1990; 263 (11): 15 29–32
  • National Heart, Lung, and Blood Institute. Expert panel report II: guidelines for the diagnosis and management of asthma. Bethesda: National Asthma Education and Prevention Program, Feb 1997
  • National Heart, Lung, and Blood Institute. International consensus report on diagnosis and management of asthma. Bethesda: Dept of Health and Human Services, 1992 March; DHHS publication No. 92–3091
  • Weinberger M. Therapeutic indications and rationale for theophylline in the management of asthma. Allergy Proc 1994; 15(6):275–82
  • Self TH, Heilker GM, Alloway RR, et al. Reassessing the therapeutic range for theophylline on laboratory report forms: the importance of 5–15 μg/ml. Pharmacotherapy 1993; 13(6):590–4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.